HERCEPTIN HYLECTA

TRASTUZUMAB AND HYALURONIDASE-OYSK · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for HERCEPTIN HYLECTA, covering 2019-02-28 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma [Phase 3]

See pricing